Clinical Trial: Expanded Access to MGAWN1 in Subjects With Suspected West Nile Neuroinvasive Disease; Suspected West Nile Virus Infection; or Substantial Accidental Exposure

Study Status: No longer available
Recruit Status: No longer available
Study Type: Expanded Access

Official Title: Expanded Access to MGAWN1 in Subjects With: Suspected West Nile Neuroinvasive Disease; Suspected West Nile Virus Infection and a Compromised Immune System; or Substantial

Brief Summary: This study will test an experimental drug called MGAWN1 for the treatment of West Nile infections.

Detailed Summary: The objective of this study is to provide expanded access to MGAWN1; the study is not intended for subjects who are eligible for and have access to non-expanded access protocols.
Sponsor: MacroGenics

Current Primary Outcome:

Original Primary Outcome:

Current Secondary Outcome:

Original Secondary Outcome:

Information By: MacroGenics

Dates:
Date Received: September 17, 2010
Date Started:
Date Completion:
Last Updated: July 5, 2011
Last Verified: July 2011